View this email in your browser ([link removed])
[link removed]
Trump's FDA Pick Can Supercharge The Agency
Forbes | March 31, 2025 | Sally C. Pipes

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration.

During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he would achieve those goals, including leveraging artificial intelligence and making other regulatory changes to streamline the drug review process.

That’s great news for patients.
Read here . . . ([link removed])
Price Controls Won't End Global Pharma Freeloading
Newsmax | Sally C. Pipes | April 2, 2025

A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing.

The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most other wealthy nations. The think tank argues that the Trump administration should find ways to force other countries to pay more for drugs — and thus pick up a more equitable share of the cost of developing new medicines.

The intent is right. Unfortunately, the paper’s methods for achieving it would slow global innovation — and fail to compel other countries to pay more for drugs.
Read more... ([link removed])

------------------------------------------------------------

Counting The Cost Of Single Payer
Right by the Bay | Sally C. Pipes | April 2, 2025

Sen. Bernie Sanders, I-Vt., is back on the road promoting Medicare for All. “We are the only major nation on earth that does not guarantee health care to all people as a human right,” he complained in a recent speech ([link removed]) in Nevada ([link removed]) .

But the Vermont senator failed to explain how he’d pay for universal health care.
Read more... ([link removed])

[link removed]

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Instagram ([link removed])
** Website ([link removed])
Copyright © 2024 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116

** ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.